Qingdao Vland Biotech INC. (SHA:603739)

Market Cap	3.56B
Revenue (ttm)	1.34B
Net Income (ttm)	59.49M
Shares Out	253.03M
EPS (ttm)	0.24
PE Ratio	58.28
Forward PE	43.01
Dividend	0.10 (0.71%)
Ex-Dividend Date	May 30, 2025

Volume	5,436,360
Average Volume	5,418,641
Open	14.05
Previous Close	14.05
Day's Range	13.84 - 14.11
52-Week Range	9.99 - 17.48
Beta	0.42
RSI	57.51
Earnings Date	Aug 28, 2025

About SHA:603739

Qingdao Vland Biotech INC. engages in the research and development, production, and sale of enzyme preparations, microecological preparations, and animal health products in China and internationally. It offers feed, industrial, and food enzymes; and probiotics, including aquaculture premixes, health products, and animal and plant probiotics. The company also offers animal vaccines and biological products, such as live and inactivated poultry, and swine vaccines, as well as egg yolk antibodies; poultry drugs comprising anti-parastic, antiviral, ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2005
• Employees: 1,535
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 603739

Financial Performance

In 2024, SHA:603739's revenue was 1.32 billion, an increase of 10.16% compared to the previous year's 1.20 billion. Earnings were 62.64 million, a decrease of -22.39%.